|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Clinical pharmacokinetics of capecitabine显示文摘 | Reiger B Blesch KS Weidekamm E | 2001 | Clin Pharmacokinet2001，40，2： | 1 |
| 2 | Clinicalpharmacokinetics of capecitabine显示文摘 | REIGNER B BLESCH K WEIDEKAMM E | 2001 | ClinPharmacokinet2001，40，2： | 1 |
| 3 | Capecitabine a Review of Its Clinical Pharmacokinetics显示文摘 | Reigner B Blesch K Weidekamm E | 2001 | Clin Pharmacokinet2001，40，2： | 1 |
| 4 | Clinical pharmacokinetics of capecitabine显示文摘 | Reigner B Blesch K Weidekamm E | 2001 | Clin Pharmacokinet2001，40，2： | 1 |
| 5 | Fleroxacin:a review of its chemistry microbiology,toxicology,pharmacokineties,clinical efficacy and safety显示文摘 | Cullmann W Geddes AM Weidekamm E | 1993 | Int J antimicrob Ag1993，2，： | 1 |
| 6 | Clinical pharmacokinetics of capecitabine 显示文摘 | REIGNER B BLESCH K WEIDEKAMM E | 2001 | Clin Pharmacokinet2001，40，2： | 1 |
| 7 | Influence of food intake and formulation on the pharmacokinetics and metabolism of bosentan, a dual endothelin receptor antagonist显示文摘 | Dingemanse J Bodin F Weidekamm E | 2002 | J Clin Pharnacol2002，42，3： | 1 |
| 8 | Fleroxacin:a review of its chemistry,microbiology,toxicology,pharmacokinetics,clinical efficacy and safety显示文摘 | Cullman W Geddes AM Weidekamm E | 1993 | Int J Antimicrob Agents1993，2，： | 1 |
| 9 | Penetration of fleroxacin into body tissues and fluids 显示文摘 | Weidekamm E Portmann R | 1993 | Am J Med1993，94，3： | 1 |
| 10 | Single and multiple dose pharmacokinetics of fleroxacin 显示文摘 | WEIDEKAMM E PORTMAM R | 1988 | J Antimicrob Chemother1988，22，： | 1 |
| 11 | Clinical pharmacokinetics of capecitabine显示文摘 | Reigner B Blesch K Weidekamm E | 2001 | Clin Pharmacokinet2001，40，： | 1 |
| 12 | Fleroxacin: a review of its chemistry, microbiology, toxicology,pharmacokinetics, clinical efficacy and safety 显示文摘 | Cullmann W Geddes AM Weidekamm E | 1993 | Int J Antimicrob Agents1993，2，4： | 1 |
| 13 | Clinical pharmacokinetics of capecitabine显示文摘 | Reigner B Blesch K Weidekamm E | | 0，，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员